Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

viatris pharmaceuticals, s.l.u. - omeprazol - cÁpsula dura gastrorresistente - 20 mg - omeprazol 20 mg - omeprazol

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

viatris pharmaceuticals, s.l.u. - duloxetina - cÁpsula dura gastrorresistente - 30 mg - duloxetina 30 mg - duloxetina

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

viatris pharmaceuticals, s.l.u. - duloxetina - cÁpsula dura gastrorresistente - 60 mg - duloxetina 60 mg - duloxetina

Den europeiske union - dansk - EMA (European Medicines Agency)

viatris limited - pirfenidon - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunosuppressiva - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Den europeiske union - finsk - EMA (European Medicines Agency)

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunosuppressantit - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Den europeiske union - svensk - EMA (European Medicines Agency)

viatris limited - pirfenidon - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunsuppressiva - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Den europeiske union - bulgarsk - EMA (European Medicines Agency)

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - Имуносупресори - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Den europeiske union - latvisk - EMA (European Medicines Agency)

viatris limited - pirfenidons - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - imūnsupresanti - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Den europeiske union - rumensk - EMA (European Medicines Agency)

viatris limited - pirfenidonă - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - imunosupresoare - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Den europeiske union - polsk - EMA (European Medicines Agency)

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - leki immunosupresyjne - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).